Company intelligence / Profile preview

Atrium

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Atrium is an active Danish organization specializing in professional development, networking, and lifelong learning for life science professionals. It offers courses covering the entire medicinal product lifecycle—from molecule discovery to marketing authorization—with a focus on regulatory affairs, clinical development, pharmacovigilance, market access, medical affairs, and related areas. The company plays a key role in upskilling talent within the Nordic pharmaceutical industry but does not itself conduct drug R&D or maintain a therapeutic pipeline

Industry: Consulting

Partnerships

Close ties with Danish Association of the Pharmaceutical Industry

Beyond the preview

Go deeper on Atrium.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Atrium.

Explore the full profile